South Africa’s public health care system has significantly run out of insulin pens which are supplied to diabetic patients as global demand has shifted to weight loss dr_gs which are using the same pen-like device for delivery.
The pharmaceutical industry is allegedly prioritising production of these weight loss drugs which are high on demand.
Novo Nordisk, the company that has supplied South Africa with human insulin in pens for a decade, opted not to renew its contract, which expired last month which has left the country with immense shortages.
“Current manufacturing capacity limitations mean that patients in some countries, including South Africa, may have limited access to our human insulins in pens,” said Ambre James-Brown, a spokeswoman for Novo Nordisk.
Novo Nordisk dominates the global market for insulin in pens and has supplied South Africa since 2014.
source:newsreportzim.com
